期刊文献+

复方苦参注射液联合激素治疗吉西他滨致间质性肺炎1例的病例报道及治疗体会 被引量:2

Case Report and Treatment Experience of Compound Matrine Injection with Crticosteroids for Gemcitabine-induced Interstitial Pneumonia
下载PDF
导出
摘要 吉西他滨是晚期非小细胞肺癌治疗的一线化疗药物,在临床广泛使用,但吉西他滨有许多不良反应,包括骨髓抑制、消化道毒性甚至间质性肺炎,这些都限制了其应用。本文主要报道1例非小细胞肺癌患者在应用吉西他滨化疗后发生间质性肺炎的病例资料及治疗体会。 Gemcitabine is a first-line chemotherapeutic drug for the treatment of advanced non-small cell lung cancer. It is widely used in clinic. However, gemcitabine may also result in many adverse effects, including myelosuppression, digestive toxicity, even interstitial pneumonitis(IP). Here, we present the clinical data and treatment experience of a case of gemcitabine-induced IP which appeared during the treatment of advanced non-small cell lung cancer.
作者 喻珣 陈建华
出处 《肿瘤药学》 CAS 2016年第2期158-160,共3页 Anti-Tumor Pharmacy
关键词 吉西他滨 间质性肺炎 非小细胞肺癌 Gemcitabine Interstitial pneumonitis Non-small cell lung cancer
  • 相关文献

参考文献16

  • 1Song Y, Baba T, Li YY, et al. Gemcitabine-induced CXCL8 expression counteracts its actions by inducing tumor neo- vascularization [J]. Biochem Biophys Res Commun, 2015, 458(2): 341-346. doi: 10,1016/j.bbrc,2015.01,112.
  • 2Khan MF, Gottesman S, Boyella R, et al. Gemcitabine- induced cardiomyopathy: a case report and review of the literature [J]. J Med Case Rep, 2014, 8: 220. doi: 10,1186/1752-1947-8-220.
  • 3Metro G, Cappuzzo F, Finocchiaro G, et al. Development ofgemcitabine in non-small cell lung cancer: the Italian con- tribution [J]. Ann Oncol, 2006, 17 Suppl 5: v37-46.
  • 4Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J]. N Engl J Med, 2002, 346(2): 92-98.
  • 5Saif MW. Pulmonary toxicity associated with gemcitabine [J]. JOP, 2010, 11(2): 189-190.
  • 6Chi DC, Brogan F, Turenne I, et al. Gemcitabine-induced pul- monary toxicity [J]. Anticancer Res, 2012, 32(9): 4147-4149.
  • 7Poole BB, Hamilton LA, Brockman MM, et al. Interstitial pneumonitis from treatment with gemcitabine [J]. Hosp Pharm, 2014, 49(9): 847-850. doi: 10,1310/hpj4909-847.
  • 8Umemura S, Yamane H, Suwaki T, et al. Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer [J]. J Cancer Res Clin Oncol, 2011, 137(10): 1469-1475. doi: 10,1007/s00432-011-1013-1.
  • 9Barl6si F, Villani P, Doddoli C, et al. Gemcitabine-induced severe pulmonary toxicity ~J~. Fundam Clin Pharmacol, 2004, 18(1): 85-91.
  • 10Danson S, Blackhall F, Hulse P, et al. Interstitial lung dis- ease in lung cancer: separating disease progression from treatment effects [J]. Drug Saf, 2005, 28(2): 103-113.

二级参考文献47

共引文献9

同被引文献5

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部